Parasomnia & RBD Video-PSG Testing

Parasomnias are sleep-related abnormal behaviors, movements, perceptions, or experiences — sleepwalking, night terrors, REM behavior disorder (RBD), confusional arousals, and various other phenomena. Distinguishing parasomnias from nocturnal seizures, psychogenic events, or psychiatric disorders requires video-PSG with extended EEG montage. The diagnosis of RBD specifically requires demonstration of REM sleep without atonia. This page covers the video-PSG technique for parasomnias, the differential of nocturnal events, and the integration with clinical history and treatment.

Categories of Parasomnias

NREM Parasomnias (Disorders of Arousal)

  • Occur during partial arousals from deep sleep.
  • Common in childhood; can persist into adulthood.
  • Types:
    • Confusional arousals: brief disorientation upon awakening, especially in children.
    • Sleepwalking (somnambulism): complex motor activity during partial arousal from slow-wave sleep.
    • Sleep terrors (pavor nocturnus): abrupt arousal with intense fear, autonomic activation, often amnestic.
    • Sleep-related eating disorder: eating during sleep.
    • Sexsomnia: sexual behavior during sleep.

REM Parasomnias

  • Occur during REM sleep.
  • Types:
    • REM behavior disorder (RBD): acting out dreams; muscle atonia absent.
    • Recurrent isolated sleep paralysis: transient inability to move at sleep onset or upon awakening.
    • Nightmare disorder: distressing dreams.
    • REM sleep-related hallucinations: during sleep-wake transitions.

Other Parasomnias

  • Sleep-related dissociative disorders.
  • Sleep enuresis.
  • Exploding head syndrome.
  • Sleep-related groaning (catathrenia).

Video-PSG Protocol

Differences from Standard PSG

  • Extended EEG montage: full 16+ channels with additional montages for seizure detection.
  • Synchronized video and audio essential.
  • Multiple muscle channels: chin EMG + bilateral upper and lower extremity EMG.
  • Behavioral observation during recording.
  • Multi-night studies sometimes needed to capture event.

Goals

  • Record episode to characterize sleep stage at onset.
  • Distinguish from nocturnal seizures.
  • Document specific abnormal motor or behavioral patterns.
  • For RBD: demonstrate REM sleep without atonia.

NREM Parasomnia Findings on Video-PSG

Typical Pattern

  • Event begins during slow-wave sleep (N3).
  • Partial arousal: increased alpha or beta superimposed on slow-wave sleep background.
  • EEG remains predominantly slow.
  • Episode lasts seconds to minutes.
  • No or limited memory of event.
  • Concentrated in first half of night (where N3 is most prominent).

Differentiation from Nocturnal Seizures

  • NREM parasomnia: emerges from N3, no ictal EEG pattern, slower onset, longer duration, no stereotypy across episodes.
  • Nocturnal seizure: often during N1 or N2; ictal EEG pattern visible; stereotyped semiology across episodes; usually shorter.
  • Frontal lobe seizures particularly mimic parasomnias.

REM Behavior Disorder (RBD)

Clinical Features

  • Acting out dreams: punching, kicking, jumping out of bed.
  • Often violent dream content.
  • Patient may injure self or bed partner.
  • Vivid recall of dream content.
  • Onset typically in middle-aged or older adults.
  • Male predominance.

Video-PSG Findings

  • REM sleep without atonia (RWA): persistent or excessive muscle activity during REM.
  • Tonic EMG activity in chin or limbs during REM.
  • Phasic limb movements.
  • Sometimes observable behavior on video.
  • Specific scoring criteria (Frauscher criteria): percentage of REM with EMG activity.

Diagnostic Criteria (AASM)

  • Repeated episodes of sleep-related vocalizations and/or complex motor behaviors.
  • Documented by PSG to occur during REM sleep.
  • REM sleep without atonia on PSG.
  • Symptoms cannot be better explained by another sleep disorder, medical condition, medication, or substance.

Idiopathic vs Symptomatic RBD

  • Idiopathic RBD: no known cause.
  • Symptomatic RBD:
    • α-synucleinopathies (Parkinson disease, DLB, MSA).
    • Narcolepsy.
    • Brainstem lesions.
    • Medications (SSRI, SNRI, mirtazapine).

Prognostic Significance

  • Idiopathic RBD is a prodromal marker for α-synucleinopathies.
  • ~80–90% of patients with idiopathic RBD develop a neurodegenerative disorder over 10–14 years (most commonly PD or DLB, less commonly MSA).
  • This makes RBD one of the strongest prodromal markers in clinical neurology.

Treatment

  • Bedroom safety: pad furniture, remove sharp objects, consider separate sleeping arrangements.
  • Pharmacologic:
    • Clonazepam 0.25–2 mg HS: traditional first-line; effective; concerns about cognitive impact in elderly.
    • Melatonin 3–12 mg HS: alternative; preferred in elderly; less sedating; preserves cognition.
  • Address medications that may exacerbate (SSRIs, SNRIs, mirtazapine).
  • Follow-up for emerging neurodegenerative disease.

Frontal Lobe Epilepsy vs Parasomnia

Features of Frontal Lobe Seizures

  • Brief (often <30 sec).
  • Stereotyped across episodes.
  • Multiple per night.
  • Hyperkinetic features (bicycling, kicking, jumping).
  • Vocalizations (screams, grunts).
  • Tonic posturing (fencer’s posture).
  • Rapid recovery.
  • Often during N1, N2, transitions.

Diagnostic Tools

  • Video-PSG: limited yield without seizure capture.
  • Inpatient long-term video EEG: gold standard for differentiation.
  • Scalp EEG often shows no ictal change in frontal lobe seizures (deep mesial origin).
  • Semiology pattern recognition essential.

Treatment Approach

  • If diagnosis uncertain, may need empirical trial of:
    • Anti-seizure medication.
    • Versus parasomnia management (sleep hygiene, clonazepam).
  • Different treatments distinguish in some cases.

Nocturnal Frontal Lobe Epilepsy (ADNFLE)

  • Familial autosomal dominant form.
  • CHRNA4, CHRNB2, CHRNA2 mutations.
  • Often misdiagnosed as parasomnia.
  • Distinguished by family history, stereotypy across episodes, response to ASMs.

Childhood Parasomnia vs Seizure

  • Common dilemma.
  • Parasomnias common in children; usually NREM type.
  • BECTS (benign rolandic epilepsy) classically with nocturnal facial motor seizures.
  • Video-PSG with extended montage often needed.
  • Sometimes overnight video EEG.

Nocturnal Movements That Aren’t Epilepsy or Parasomnia

  • Periodic limb movements: stereotyped repetitive limb movements; PLM index quantifies.
  • Bruxism: tooth grinding.
  • Hypnic jerks: sudden limb jerks at sleep onset; normal.
  • Restless legs: occurs in evenings, alleviates with movement, urge to move.

Sleep-Related Eating Disorder (SRED)

  • Eating during partial arousal from NREM sleep.
  • Often unusual food choices (raw food, frozen items).
  • Patient may have no memory or limited memory.
  • Treatment: topiramate, scheduled eating, sleep hygiene.

Sexsomnia

  • Sexual behavior during partial arousal from sleep.
  • Patient often unaware.
  • Important medico-legal implications.
  • PSG confirmation of NREM origin.

Catathrenia (Sleep-Related Groaning)

  • Prolonged groaning during expiration in REM.
  • Loud, audible to bedmates.
  • Benign but socially disruptive.

Treatment Principles

NREM Parasomnias

  • Most childhood NREM parasomnias resolve with age.
  • Bedroom safety.
  • Reduce sleep deprivation.
  • Stress reduction.
  • If severe or persistent: clonazepam at bedtime.
  • Scheduled awakenings (anticipating episodes).

RBD

  • Bedroom safety + medication (melatonin or clonazepam).
  • Follow-up for α-synucleinopathy emergence.

Frontal Lobe Seizures

  • ASMs (carbamazepine, oxcarbazepine, lamotrigine, levetiracetam).
  • Surgical evaluation for refractory cases.

🔍 Did You Know?

The recognition that idiopathic REM sleep behavior disorder (RBD) is a prodromal marker of α-synucleinopathy — predicting Parkinson disease, dementia with Lewy bodies, or multiple system atrophy with remarkable specificity — has transformed how we think about the early stages of neurodegeneration. Long-term cohort studies have shown that ~80–90% of patients with idiopathic RBD develop a defined α-synucleinopathy within 14 years, with Parkinson disease being most common. This prodromal phase can last 10–20 years, providing a unique window of time when potential disease-modifying therapies could potentially be introduced. The clinical implication is profound: diagnosing idiopathic RBD is more than diagnosing a sleep disorder — it’s identifying a patient at substantially elevated risk for neurodegeneration. This has led to: (1) careful follow-up of RBD patients for emerging neurodegenerative symptoms; (2) inclusion of RBD patients in clinical trials of α-synuclein-targeted therapies; (3) family education about the prognostic significance. The diagnostic workflow requires: video-PSG demonstrating REM sleep without atonia AND clinical history of dream enactment (both must be present). For practicing neurologists, the take-home is that any patient reporting “acting out dreams” deserves polysomnography to confirm RBD, and a confirmed diagnosis warrants baseline neurological evaluation for prodromal motor or cognitive features and structured follow-up. The lesson generalizes: recognizing prodromal phases of neurodegenerative diseases is becoming increasingly important, with implications for early intervention as disease-modifying therapies emerge.

Pitfalls and Pearls

  • NREM parasomnias: arise from N3 (slow-wave sleep); first half of night; childhood predominant.
  • REM parasomnias: arise from REM; second half of night.
  • RBD diagnosis: clinical history + REM sleep without atonia on PSG.
  • RBD as prodrome: 80–90% develop α-synucleinopathy in 14 years.
  • Video-PSG essential: distinguishes parasomnia from seizure.
  • Frontal lobe seizures: brief, stereotyped, multiple per night, hyperkinetic; often mimic parasomnia.
  • Long-term video EEG: for unclear cases.
  • NREM parasomnia vs seizure: arising from N3 vs N1/N2; non-stereotyped vs stereotyped; longer vs shorter.
  • Bedroom safety: first-line for RBD; pad furniture, remove sharp objects.
  • RBD treatment: melatonin (preferred in elderly), clonazepam.
  • Frauscher criteria: scoring for REM sleep without atonia.
  • Symptomatic RBD: SSRIs/SNRIs, narcolepsy, brainstem lesions.
  • Childhood NREM parasomnias: usually resolve with age; address sleep deprivation.
  • SRED: topiramate; lock kitchen; sleep hygiene.
  • Sexsomnia: medico-legal implications; PSG confirmation.
  • RBD follow-up: for emerging Parkinson disease, DLB, or MSA features.
  • Multi-night studies: sometimes needed to capture event.

References

  1. American Academy of Sleep Medicine. International Classification of Sleep Disorders. 3rd ed. American Academy of Sleep Medicine; 2014.
  2. Postuma RB, Iranzo A, Hu M, et al. Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study. Brain. 2019;142(3):744-759.
  3. Frauscher B, Iranzo A, Gaig C, et al. Normative EMG values during REM sleep for the diagnosis of REM sleep behavior disorder. Sleep. 2012;35(6):835-847.
  4. Boeve BF. REM sleep behavior disorder: updated review of the core features, the RBD-neurodegenerative disease association, evolving concepts, controversies, and future directions. Ann N Y Acad Sci. 2010;1184:15-54.
  5. Tinuper P, Bisulli F, Cross JH, et al. Definition and diagnostic criteria of sleep-related hypermotor epilepsy. Neurology. 2016;86(19):1834-1842.
  6. Schenck CH, Mahowald MW. REM sleep behavior disorder: clinical, developmental, and neuroscience perspectives 16 years after its formal identification in SLEEP. Sleep. 2002;25(2):120-138.